Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
8.04
-0.85 (-9.56%)
At close: Aug 15, 2025, 12:55 PM
Cyclacel Pharmaceuticals Fail-to-Deliver
Total FTD Shares
12.72K
Below Average
FTD / Avg. Volume
0.68%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Cyclacel Pharmaceuticals Inc. has
12,721
shares failed to deliver, representing 0.68%
of the average daily volume of
1,884,237
shares. Over the past year, the monthly average FTD is
33,074
shares, with the current level 62% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 3.31 | 12.72K | -30.48% |
Jun 26, 2025 | 5.25 | 18.3K | +746.74% |
May 29, 2025 | 24 | 2.16K | -99.50% |
Apr 30, 2025 | 61.97 | 430.35K | +13323.30% |
Mar 28, 2025 | 71.76 | 3.21K | -87.19% |
Feb 28, 2025 | 79.56 | 25.03K | +1783.22% |
Jan 23, 2025 | 84 | 1.33K | -91.22% |
Dec 31, 2024 | 90.24 | 15.14K | +1959.46% |
Nov 25, 2024 | 82.56 | 735 | -68.84% |
Oct 30, 2024 | 157.68 | 2.36K | +16.49% |
Sep 30, 2024 | 237.6 | 2.02K | -33.72% |
Aug 30, 2024 | 252.48 | 3.06K | -23.61% |
Jul 26, 2024 | 408 | 4K | -63.42% |
Jun 27, 2024 | 408 | 10.93K | +41946.15% |
May 29, 2024 | 492 | 26 | -99.98% |
Apr 30, 2024 | 508.8 | 110.18K | +10494.04% |
Mar 28, 2024 | 506.38 | 1.04K | +18.72% |
Feb 23, 2024 | 636 | 876 | -90.87% |
Jan 31, 2024 | 537.6 | 9.59K | +9786.60% |
Dec 28, 2023 | 681.6 | 97 | -56.70% |
Nov 30, 2023 | 1079.46 | 224 | -63.81% |
Oct 27, 2023 | 2034.78 | 619 | -85.48% |
Sep 29, 2023 | 1276.28 | 4.26K | +6262.69% |
Aug 09, 2023 | 1986.21 | 67 | -99.69% |
Jul 28, 2023 | 2335.23 | 21.83K | +34006.25% |
Jun 30, 2023 | 2119.7 | 64 | -97.95% |
May 31, 2023 | 2302.85 | 3.12K | +50.68% |
Apr 28, 2023 | 2194.9 | 2.07K | -44.81% |
Mar 30, 2023 | 2131.93 | 3.75K | +1250.36% |
Feb 28, 2023 | 3022.49 | 278 | -98.55% |
Jan 31, 2023 | 3252.05 | 19.17K | n/a |